These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7053914)

  • 1. Effect of acute vasopressin infusion on blood pressure and plasma angiotensin II in normotensive and DOCA-salt hypertensive rats.
    Morton JJ; Garcia del Rio C; Hughes MJ
    Clin Sci (Lond); 1982 Feb; 62(2):143-9. PubMed ID: 7053914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
    Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
    J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular binding sites and biological activity of vasopressin in DOCA-salt hypertensive rats.
    Larivière R; St-Louis J; Schiffrin EL
    J Hypertens; 1988 Mar; 6(3):211-7. PubMed ID: 3283226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension.
    Wang H; McNeill JR
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin antagonist reduces hemodynamic responses to vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; Wilson TW; McNeill JR
    Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2511-7. PubMed ID: 11709418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of angiotensin receptors in the anterior hypothalamic preoptic area lowers blood pressure in DOCA-salt hypertensive rats.
    Kubo T; Yamaguchi H; Tsujimura M; Hagiwara Y; Fukumori R
    Hypertens Res; 2000 Mar; 23(2):109-18. PubMed ID: 10770257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of the antihypertensive effect of vasopressin withdrawal to sodium excretion in the Doca-salt hypertensive rat.
    Wang H; Wilson N; McNeill JR
    Clin Invest Med; 1993 Oct; 16(5):348-57. PubMed ID: 8261688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Withdrawal-induced antihypertensive effect of vasopressin in Doca-salt hypertension.
    Chiu EK; McNeill JR
    Am J Hypertens; 1989 Jun; 2(6 Pt 1):458-61. PubMed ID: 2757802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; McNeill JR
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exacerbated effects of prorenin on hypothalamic magnocellular neuronal activity and vasopressin plasma levels during salt-sensitive hypertension.
    Pitra S; Worker CJ; Feng Y; Stern JE
    Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H496-H504. PubMed ID: 31274353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats.
    O'Donaughy TL; Qi Y; Brooks VL
    Hypertension; 2006 Oct; 48(4):658-63. PubMed ID: 16966581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chronic angiotensin-converting enzyme blockade on pressor responses to exogenous angiotensin II, noradrenaline and vasopressin in deoxycorticosterone acetate salt (DOCA)-induced hypertensive rats.
    Gan EK; Abas A; Latiff A
    Jpn J Pharmacol; 1984 Oct; 36(2):147-51. PubMed ID: 6096611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of vasopressin in the mechanism maintaining hypertension in the rat.
    Yazaki Y; Ohuchi Y; Ashida T; Saito T
    Jpn Circ J; 1981 Sep; 45(9):1116-20. PubMed ID: 7300021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depressor effects of captopril in DOCA-salt hypertensive rats: role of vasopressin.
    Igarashi Y; Suzuki H; Itaya Y; Kondo K; Saruta T
    J Hypertens; 1985 Apr; 3(2):149-53. PubMed ID: 3894513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pressor responses to vasopressin in pigs and sheep with DOCA hypertension.
    Ling WD; Brooks DP; Crofton JT; Share L; Bohr DF
    Am J Physiol; 1989 Jan; 256(1 Pt 2):H101-4. PubMed ID: 2912171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of intracerebroventricular injection of vasopressin in unanaesthetized normotensive and DOCA-salt hypertensive rats.
    Berecek KH; Mah SC; Baum P; Hofbauer KG
    J Hypertens Suppl; 1984 Dec; 2(3):S29-31. PubMed ID: 6599674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraventricular nucleus lesions attenuate the development of hypertension in DOCA/salt-treated rats.
    Nakata T; Takeda K; Itho H; Hirata M; Kawasaki S; Hayashi J; Oguro M; Sasaki S; Nakagawa M
    Am J Hypertens; 1989 Aug; 2(8):625-30. PubMed ID: 2570597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenteric vascular responses to vasopressin during development of DOCA-salt hypertension in male and female rats.
    Stallone JN
    Am J Physiol; 1995 Jan; 268(1 Pt 2):R40-9. PubMed ID: 7840337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of firibastat in combination with enalapril and hydrochlorothiazide on blood pressure and vasopressin release in hypertensive DOCA-salt rats.
    Marc Y; Hmazzou R; De Mota N; Balavoine F; Llorens-Cortes C
    Biomed Pharmacother; 2021 Aug; 140():111682. PubMed ID: 34020248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinin-mediated antihypertensive effect of captopril in deoxycorticosterone acetate-salt hypertension.
    Chen K; Zhang X; Dunham EW; Zimmerman BG
    Hypertension; 1996 Jan; 27(1):85-9. PubMed ID: 8591894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.